MAP-IE-PR - CISMeF

Preferred Label : MAP-IE-PR;

NCIt definition : An experimental treatment arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) plus a regimen of ifosfamide and etoposide (IE) post-operatively after poor response to the MAP regimen pre-operatively.;

NCI Metathesaurus CUI : CL1779129;

Details

Origin ID

C186772;

UMLS CUI

C5670741;

Semantic type(s)
- Research Activity [UMLS semantic type]
concept_is_in_subset
- OS Subject Characteristics Table [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients